An Adipocyte-Driven Mechanism For Weight Regain After Weight Loss: The Yo-Yo Effect
ADIPOSTRESS
1 other identifier
interventional
58
1 country
1
Brief Summary
Almost half of the Dutch population is currently characterized by overweight and obesity. Losing weight is not the problem in obesity treatment, it is the seemingly obligatory weight regain after weight loss: the yoyo-effect. The primary objective of this study is to investigate the association between the weight-loss-induced cellular stress response and the rate of weight regain. The secondary objective is to investigate the differences in cellular stress response and weight regain after rapid and slow weight loss. To investigate this, subjects will receive meal replacements replacing either all or part of the daily meals during the intervention period. THe first group will consume 500 kcal/d diet for 5 weeks while the second group consumes a 1250 kcal/d diet for 3 months, both followed by 1 week normalization and a 2 week strict weight maintenance diet. During the 9-month follow-up period subjects will receive dietary advice according to the Dutch recommendations for healthy eating. The association between the amount of weight regain after the weight loss period and changes in adipokines, parameters of adipocyte metabolism, in vivo adipose tissue metabolism, adipocyte extracellular matrix gene expression profiles, adipocyte stress protein expression and gene polymorphisms in selected genes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Mar 2012
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 12, 2012
CompletedFirst Posted
Study publicly available on registry
March 21, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedDecember 23, 2014
December 1, 2014
2.7 years
March 12, 2012
December 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change in weight following weight loss
VLCD diet group
at 9 weeks and at 46 weeks
change in weight following weight loss
LCD diet group
at 16 weeks and at 53 weeks
Secondary Outcomes (88)
change in adipokine profile due to dietary intervention (VLCD-group)
at baseline and after 5 weeks of VLCD diet
change in adipokine during weight stable-period (VLCD-group)
after 5 weeks of VLCD diet and after 9 weeks
change in adipokine profile during follow-up (VLCD-group)
at 9 weeks and after follow-up at 46 weeks
change in adipokine profile due to dietary intervention (LCD-group)
at baseline and after 12 weeks of LCD diet
change in adipokine profile during weight-stable period (LCD-group)
after 12 weeks of LCD diet and at 16 weeks
- +83 more secondary outcomes
Study Arms (2)
Very Low Calorie Diet
EXPERIMENTALLow Calorie Diet
ACTIVE COMPARATOR1250 kcal diet in which Modifast is given in combination with a normal diet
Interventions
modifast intensive diet replacing all regular meals (500 kcal/d) for 5 weeks
Combination of modifast and regular diet (1250 kcal/d) for 3 months
Eligibility Criteria
You may qualify if:
- Age (years): 20-65
- Body Mass Index (kg/m2): 28-35
- Non-smokers
You may not qualify if:
- Subjects using prescription medication, or suffering from diseases or conditions that might influence the outcome of the study: this concerns diseases/medication that influence body weight regulation (malabsorption, untreated hypo/hyperthyroidism, eating disorders, systemic use of steroids, etc.) and obesity-related cardiovascular risk factors (heart disease, systolic and diastolic blood pressures \> 160/100 mmHg, blood glucose \> 6.1 mmol L-1, blood cholesterol \> 7 mmol L-1, blood triglycerides \> 3 mmol L-1)
- marked alcohol consumption \> 21 alcoholic units week-1 (male), or \>14 alcoholic units week-1 (female)
- planned major changes in physical activity during the study to an extent that might interfere with the study outcome as judged by the investigator;
- blood donation within the past 2 months prior to the study
- weight change of \>3 kg within 2 months prior to the study
- psychiatric disease (based on medical history only)
- pregnant or lactating women, or women planning to become pregnant within the next 12 months
- surgically treated obesity
- participation in other clinical studies within the last 3 months
- drug abuse (based on clinical judgment)
- unable to give informed consent
- unable to engage in a low-calorie diet
- unable to lose more then 8% of body weight after weight-loss period
- following a special diet (vegetarian, Atkins or other).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University
Maastricht, Limburg, 6200 MD, Netherlands
Related Publications (6)
Qiao Q, Bouwman FG, van Baak MA, Roumans NJT, Vink RG, Mariman ECM. Plasma Levels of Triglycerides and IL-6 Are Associated With Weight Regain and Fat Mass Expansion. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1920-1929. doi: 10.1210/clinem/dgac198.
PMID: 35366329DERIVEDTareen SHK, Kutmon M, de Kok TM, Mariman ECM, van Baak MA, Evelo CT, Adriaens ME, Arts ICW. Stratifying cellular metabolism during weight loss: an interplay of metabolism, metabolic flexibility and inflammation. Sci Rep. 2020 Feb 3;10(1):1651. doi: 10.1038/s41598-020-58358-z.
PMID: 32015415DERIVEDRoumans NJT, Wang P, Vink RG, van Baak MA, Mariman ECM. Combined Analysis of Stress- and ECM-Related Genes in Their Effect on Weight Regain. Obesity (Silver Spring). 2018 Mar;26(3):492-498. doi: 10.1002/oby.22093. Epub 2018 Feb 5.
PMID: 29399976DERIVEDVink RG, Roumans NJ, van der Kolk BW, Fazelzadeh P, Boekschoten MV, Mariman EC, van Baak MA. Adipose Tissue Meal-Derived Fatty Acid Uptake Before and After Diet-Induced Weight Loss in Adults with Overweight and Obesity. Obesity (Silver Spring). 2017 Aug;25(8):1391-1399. doi: 10.1002/oby.21903. Epub 2017 Jun 22.
PMID: 28639346DERIVEDRoumans NJ, Vink RG, Fazelzadeh P, van Baak MA, Mariman EC. A role for leukocyte integrins and extracellular matrix remodeling of adipose tissue in the risk of weight regain after weight loss. Am J Clin Nutr. 2017 May;105(5):1054-1062. doi: 10.3945/ajcn.116.148874. Epub 2017 Mar 15.
PMID: 28298393DERIVEDVink RG, Roumans NJ, Cajlakovic M, Cleutjens JPM, Boekschoten MV, Fazelzadeh P, Vogel MAA, Blaak EE, Mariman EC, van Baak MA, Goossens GH. Diet-induced weight loss decreases adipose tissue oxygen tension with parallel changes in adipose tissue phenotype and insulin sensitivity in overweight humans. Int J Obes (Lond). 2017 May;41(5):722-728. doi: 10.1038/ijo.2017.38. Epub 2017 Feb 9.
PMID: 28179648DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marleen van Baak, Professor
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2012
First Posted
March 21, 2012
Study Start
March 1, 2012
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
December 23, 2014
Record last verified: 2014-12